NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
57.54
-0.38 (-0.66%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close57.92
Open58.01
Bid0.00 x 800
Ask0.00 x 900
Day's Range57.09 - 58.01
52 Week Range43.51 - 72.41
Volume240,340
Avg. Volume404,306
Market Cap2.986B
Beta (3Y Monthly)1.34
PE Ratio (TTM)61.67
EPS (TTM)0.93
Earnings DateJul 29, 2019 - Aug 2, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est61.67
Trade prices are not sourced from all markets
  • NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion
    PR Newswire16 hours ago

    NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion

    SAN DIEGO, June 17, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-O, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This further expands the application of the Company's Advanced Materials Science™ (AMS) portfolio to more of its procedural offerings and the most commonly performed procedure in the spine industry. Modulus TLIF-O features porous surface technology that, based on pre-clinical data, provides a favorable environment for bone in-growth and bone on-growth, and consistently achieves stronger osseointegration than solid implants with smooth or rough surfaces.1-4 The porous and roughened endplate design promotes new bone on-growth at four weeks and demonstrates the greatest integration strength by 12 weeks compared to alternative implant materials.5 Modulus TLIF-O's lattice structure is optimized for each implant size through NuVasive's proprietary algorithm that balances strength and radiolucency, while also mimicking the stiffness of bone.5 This optimized lattice structure enables enhanced imaging for visualization of spinal fusion compared to solid titanium interbody implants.

  • NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards
    PR Newswire6 days ago

    NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards

    SAN DIEGO, June 12, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform was voted a gold winner in the Radiological, Imaging and Electromechanical Devices category at the 2019 Medical Design Excellence Awards (MDEA) held in New York City on June 11, 2019. The LessRay platform is built on a proprietary algorithm that captures and enhances low-dose, low-quality images to produce images with similar diagnostic capabilities as conventional full-dose images. This technology has the ability to reduce radiation emissions to the operating room (OR) staff and patient by 75 percent compared to standard fluoroscopy.1 Additionally, LessRay contains a number of surgical efficiency features designed to save time during spine surgery, which can decrease time under anesthesia for the patient.

  • Markit8 days ago

    See what the IHS Markit Score report has to say about NuVasive Inc.

    NuVasive Inc NASDAQ/NGS:NUVAView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for NUVA with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on May 28. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $118 million over the last one-month into ETFs that hold NUVA are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Why Is NuVasive (NUVA) Down 3.9% Since Last Earnings Report?
    Zacks18 days ago

    Why Is NuVasive (NUVA) Down 3.9% Since Last Earnings Report?

    NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System
    PR Newswire19 days ago

    NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System

    SAN DIEGO, May 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions announced today that the Company's SpineTRACK Registry submitted successful quality performance data to the Centers of Medicare & Medicaid Services (CMS) on behalf of healthcare providers at Southern Oregon Neurosurgical & Spine Associates (SONSA) for the Merit-based Incentive Payment System (MIPS). As a result, SONSA providers are eligible for a positive adjustment of up to seven percent on all Medicare reimbursements for the 2020 payment year.

  • Is NuVasive, Inc. (NASDAQ:NUVA) A Financially Sound Company?
    Simply Wall St.20 days ago

    Is NuVasive, Inc. (NASDAQ:NUVA) A Financially Sound Company?

    Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as NuVasive, Inc...

  • Thomson Reuters StreetEvents21 days ago

    Edited Transcript of NUVA earnings conference call or presentation 1-May-19 8:30pm GMT

    Q1 2019 NuVasive Inc Earnings Call

  • Here's Why You Should Retain NuVasive (NUVA) Stock for Now
    Zacks21 days ago

    Here's Why You Should Retain NuVasive (NUVA) Stock for Now

    Investor confidence in the stock is high on NuVasive's (NUVA) sturdy spine business.

  • VREX vs. NUVA: Which Stock Is the Better Value Option?
    Zackslast month

    VREX vs. NUVA: Which Stock Is the Better Value Option?

    VREX vs. NUVA: Which Stock Is the Better Value Option?

  • NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting
    PR Newswirelast month

    NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting

    SAN DIEGO, May 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company continues its commitment to the Society of Lateral Access Surgery (SOLAS) as a Global Partner, the leading sponsorship level in the partnership program, at the 12th annual SOLAS meeting being held May 16-18, 2019 in Miami, Florida. NuVasive will also participate in exhibit and workshop programs, featuring its comprehensive approach to lateral single-position surgery with the X360™ system integrated with Surgical Intelligence™. During the meeting, NuVasive will host a lunch symposia, X360 powered by Surgical Intelligence, presented by Brett Braly, MD, and Brian Kwon, MD, on May 17, 2019 from 12:45 to 2:15 p.m. ET.

  • NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019
    PR Newswirelast month

    NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019

    A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. NuVasive, Inc. (NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. With more than $1 billion in revenues, NuVasive has approximately 2,600 employees and operates in more than 50 countries serving surgeons, hospitals and patients.

  • How NuVasive, Inc. (NASDAQ:NUVA) Can Impact Your Portfolio Volatility
    Simply Wall St.last month

    How NuVasive, Inc. (NASDAQ:NUVA) Can Impact Your Portfolio Volatility

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Anyone researching NuVasive, Inc. (NASDAQ:NUVA) might want to consider the historical volatility of t...

  • NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong
    Zacks2 months ago

    NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong

    NuVasive's (NUVA) solid international sales in Q1 boost investor confidence in the stock.

  • NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript

    NUVA earnings call for the period ending March 31, 2019.

  • NuVasive Straightens Up to Start 2019
    Motley Fool2 months ago

    NuVasive Straightens Up to Start 2019

    The spinal-surgery specialist gave investors solid performance.

  • NuVasive (NUVA) Q1 Earnings and Revenues Top Estimates
    Zacks2 months ago

    NuVasive (NUVA) Q1 Earnings and Revenues Top Estimates

    NuVasive (NUVA) delivered earnings and revenue surprises of 29.27% and 2.21%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    NuVasive: 1Q Earnings Snapshot

    The San Diego-based company said it had net income of 18 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to 53 cents per share. The results surpassed Wall Street ...

  • NuVasive Announces First Quarter 2019 Financial Results
    PR Newswire2 months ago

    NuVasive Announces First Quarter 2019 Financial Results

    SAN DIEGO , May 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...

  • Benzinga2 months ago

    A Preview Of NuVasive's Q1 Earnings

    On Wednesday, May 1, NuVasive (NASDAQ: NUVA ) will release its latest earnings report. Check out Benzinga's preview to understand the implications. Earnings and Revenue NuVasive earnings will be near 41 ...

  • Is NuVasive, Inc. (NUVA) A Good Stock To Buy?
    Insider Monkey2 months ago

    Is NuVasive, Inc. (NUVA) A Good Stock To Buy?

    Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon and Netflix ranked among the top 30 picks and both lost more than 25%. Facebook, which was the second most popular stock, lost 20% amid uncertainty regarding the interest rates and tech […]

  • NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks2 months ago

    NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth

    NuVasive (NUVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.